Precursors of Etiocholanolone and Androsterone in Adrenal Carcinoma
M. B. Lipsett
Abstract
M. B. Lipsett
Abstract
The precursor of urinary androsterone and etiocholanolone was shown to be dehydroepiandrosterone in 2 ovariectomized women. In 3 women with Cushing's syndrome due to adrenal carcinoma, there were other major precursors of etiocholanolone and, to a lesser extent, of androsterone. It was suggested that these other precursors were 17α-hydroxyprogesterone and compound S. In one patient with adrenal cancer who excreted only 11-deoxy-17-ketosteroids, etiocholanolone was derived almost entirely from dehydroepiandrosterone. The secretion rate of DHA was 7 and 11 mg daily in 2 ovariectomized women. In 4 patients with adrenal carcinoma, it ranged from 28 mg to 390 mg daily.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The precursor of urinary androsterone and etiocholanolone was shown to be dehydroepiandrosterone in 2 ovariectomized women. In 3 women with Cushing's syndrome due to adrenal carcinoma, there were other major precursors of etiocholanolone and, to a lesser extent, of androsterone. It was suggested that these other precursors were 17α-hydroxyprogesterone and compound S. In one patient with adrenal cancer who excreted only 11-deoxy-17-ketosteroids, etiocholanolone was derived almost entirely from dehydroepiandrosterone. The secretion rate of DHA was 7 and 11 mg daily in 2 ovariectomized women. In 4 patients with adrenal carcinoma, it ranged from 28 mg to 390 mg daily.
Key concepts: Etiocholanolone, Androsterone, Endocrinology, Internal medicine, Dehydroepiandrosterone, Ovariectomized rat, Chemistry, Medicine